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Abstract
Background: Multicentric gliomas are well-separated tumors in different locations of the brain, without anatomical
continuity between lesions. We report a rare case of multicentric gliomas that occurred in both supra- and infratentorial
regions with different histopathology.
Case presentation: A 27-year-old man was admitted to our hospital with mild motor weakness of the right leg.
Magnetic resonance imaging (MRI) showed a large tumor occupying the left insula, extending to the left basal
ganglia, so tumor resection was performed. Histological diagnosis was diffuse astrocytoma. Tumor cells showed
sporadic immunoreactivity for p53 and negative immunostaining for epidermal growth factor receptor (EGFR).
Postoperative course was uneventful, and adjuvant therapy was not performed. At 7 months after surgery, MRI
disclosed a left cerebellar tumor displaying an irregular ring formation on enhancement with gadolinium (Gd)
and marked peritumoral edema. MRI studies including T2-weighted imaging demonstrated that this paravermian
tumor had no contact with the initial left insular tumor. In addition, MRI studies of the whole neuraxis, cytological
examination of the cerebrospinal fluid, and neurological findings demonstrated that no dissemination had
occurred through the subarachnoid space or as intracerebral metastases. Therefore, the second surgery was
performed. Histological diagnosis was glioblastoma. Immunohistochemistry revealed that most tumor cells were
positively stained for both p53 and EGFR but negatively stained for isocitrate dehydrogenase 1 (IDH1).
Conclusions: We reported a case of multicentric gliomas occurring in both supra- and infratentorial regions with
different histopathology. Immunohistochemical examinations suggest that different genetic pathways may participate
in the occurrence of these tumors.
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Background
Multicentric gliomas are well-recognized entities, but
their occurrence is still rare. Among these, gliomas aris-
ing from both supra- and infratentorial regions with dif-
ferent histology are very rare [1–4]. We report the case
of a patient with multicentric gliomas whose tumors oc-
curred in both supra- and infratentorial regions with dif-
ferent histological types. One was diffuse astrocytoma in
the left insula, and the other was glioblastoma in the
cerebellum. We present the case and discuss the possible
pathogeneses of multicentric gliomas.
Case presentation
A 27-year-old man began to experience disorientation
and visited his family doctor. Although magnetic reson-
ance imaging (MRI) showed an abnormal mass in the
left insula, extending to the left basal ganglia, he was
followed without therapy. The tumor gradually increased
in size, and he was referred to our department. Neuro-
logical examination on admission revealed clear con-
sciousness and no abnormality in cranial nerve functions
other than mild weakness of the right leg (manual
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muscle test: 4/V). MRI on initial admission showed a
tumor mass (diameter, 70 mm) extending from the left
insula to the basal ganglia. The lesion was hypointense
on T1-weighted imaging and hyperintense on T2-
weighted imaging. The lesion was not enhanced on ad-
ministration of gadolinium (Gd) (Fig. 1a–c). No other le-
sions were identified in the brain, including the
cerebellum (Fig. 1d, e). Cerebral angiography disclosed
no apparent tumor staining or abnormal vessels. As in-
traoperative histological examination revealed that the
left insular tumor was a low-grade glioma, the tumor
was partially resected under the electrophysiological
monitoring using a motor-evoked potential to avoid ser-
ious neurological complications. Postoperative histo-
logical diagnosis was diffuse astrocytoma (World Health
Organization (WHO) grade II astrocytoma) (Fig. 2a).
Immunohistochemical studies showed that Ki-67 (MIB-
1) proliferation-related labeling index was very low at
1 % or less, and tumor cells revealed sporadic immuno-
reactivity for p53, but a negative staining for epidermal
growth factor receptor (EGFR) (Fig. 2b–d). Postoperative
course was uneventful, and adjuvant therapy was not
performed because of a very low MIB-1 labeling index in
the tumor.
MRI performed 3 months after surgery did not show
any growth of the left insular tumor or any other lesion
(Fig. 3). At 7 months after surgery, the patient presented
with headache, nausea, and cerebellar symptoms. MRI
disclosed a left cerebellar tumor displaying an irregular
ring formation on enhancement with Gd and marked
peritumoral edema (Fig. 4a–c). The residual supratentor-
ial tumor remained unchanged compared to MRI
7 months earlier (Fig. 4d, e). Total resection of the cere-
bellar tumor was performed (Fig. 5) and a ventriculo-
peritoneal shunt was placed because of persisting hydro-
cephalus. Histological examination revealed that the
tumor showed high cellularity, cellular and nuclear ana-
plasia, and mitotic figures and also had prominent
microvascular proliferation and large necrosis often ac-
companied with pseudopalisading of tumor cells, leading
to diagnose as glioblastoma (WHO grade IV astrocy-
toma) (Fig. 6a, b). Ki-67 proliferation-related labeling
index was very high, at 42.8 %, and most tumor cells
showed positive immunostains for both p53 and EGFR
(Fig. 6c–e), but a negative staining for isocitrate de-
hydrogenase 1 (IDH1) (Fig. 6f ). Extended focal radio-
therapy at a total dose of 50 Gy and one course of
chemotherapy comprising carboplatin and etoposide
were performed. Nine months after radio-chemotherapy,
the patient died of dissemination from the infratentorial
tumor through the ventricle space, but residual insular
tumor remained unchanged. As permission of autopsy
could not be obtained from his family, we could not
confirm the histology of these lesions.
Fig. 1 Preoperative axial T2-weighted (a), T1-weighted (b), and gadolinium (Gd) enhanced T1-weighted (c) magnetic resonance (MR) images
showing a tumor mass in the left insula with a mild mass effect. The tumor was not enhanced on the administration of Gd. Axial T2-weighted
(d) and Gd enhanced T1-weighted (e) MR images obtained at the same time showing no tumor in the cerebellum
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The clinical study of the abovementioned case report
was approved by the Ethics Committee for Clinical Re-
search of Ehime University Hospital, and informed con-
sent was obtained from the patient prior to initiating the
study.
Discussion
As for the definition of multicentric gliomas, Batzdorf
and Malamud described the criteria that multifocal
tumors should be distinguished from multicentric tu-
mors [3]. The multifocal tumors result from invasion
or growth by established routes such as commissural
or tract fibers. Otherwise, such tumors occur by
spread via cerebrospinal fluid channels or local
metastasis. In contrast, multicentric gliomas occur in
a distant site to each other, such as in different lobes
or hemispheres, and there is no connecting pathway
between these tumors. It is also emphasized that
these two tumors occur at different times. Conversely,
in a brain autopsy study, Mishra et al. stated that
even when tumor connectivity is missing based on
macroscopic findings, the possibility of microscopic
connectivity cannot be completely excluded [4]. Mal-
colm et al. suggested that gliomas occurring in both
supra- and infratentorial regions may be considered
true multicentric gliomas, as they arise the different
compartment of the brain without gross or micro-
scopic connections [5]. In the present case, the two
Fig. 2 Photomicrographs showing histopathology of the left insular tumor. Tumor cells presenting nuclear atypia such as small and semicircular
nuclei were increased in number with microcystic stroma. No mitotic cells were observed (hematoxylin and eosin ×400, scale bar: 50 μm)
(a). Immunohistochemistry for MIB-1 showing a very low Ki-67 (MIB-1) proliferation-related labeling index (1 % or less) (b). Immunohistochemistry for
p53 (c) and epidermal growth factor receptor (EGFR) (d) revealing sporadic immunoreactivity of tumor cells for p53, but no immunoreactivity for EGFR.
b–d ×400, scale bar: 50 μm
Fig. 3 MR images at 3 months after the first surgery showing no growth of the left frontal tumor and no lesion at the other sites including the
cerebellum. Axial T2-weighted image (a), axial (b), and sagittal (c) Gd-enhanced T1-weighted MR images
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tumors arose in different locations of supra- and infraten-
torial regions (one in the left insula; the other in the cere-
bellum), and no macroscopic connectivity was apparent
on MRI. Although the possibility of local intracerebral
metastasis could not be excluded, these two tumors were
diagnosed as multicentric gliomas because they showed
different histological findings.
Multicentric gliomas more often affect middle-aged
men and show rapid tumor progression, and the progno-
sis is extremely poor. Many reported cases of
multicentric gliomas occur in the supratentorial com-
partment, and occurrence in both supra- and infraten-
torial regions is very rare [4–7]. To the best of our
knowledge, only 11 cases of multicentric gliomas arising
Fig. 4 MR images at 7 months after the first surgery showing occurrence of a large tumor at the paravermian region of the left cerebellum. The
tumor was enhanced in a ring-like fashion by Gd and accompanied by marked peritumoral brain edema. Axial T2-weighted (a), T1-weighted (b),
and Gd-enhanced T1-weighted (c) MR images. MR images disclosing no tumor growth of the left insular tumor and hydrocephalus. Axial T2-
weighted (d) and Gd-enhanced T1-weighted (e) MR images
Fig. 5 MR images at 1 week after the second surgery revealing total resection of the cerebellar tumor. Axial T2-weighted (a) and Gd-enhanced
T1-weighted (b) MR images. Brain edema around the vermis still moderately persists, and the fourth ventricle remains obstructed
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above and below the tentorium have been reported, and
all exhibited different histological findings [4–12]. Mean
patient age is 37.8 years (range, 11–63 years). No clear
gender differences have been identified. These tumors
arise predominantly in the cerebral hemisphere and
cerebellum, and all cerebellar tumors have been located
around the fourth ventricle, as in the present case.
Histological examination of these 11 patients revealed
that both supra- and infratentorial tumors showed high-
grade gliomas in five patients. In another five patients,
when one tumor located in either supra- or infratentor-
ial region showed high grade, the other located in the
different region was low grade (including the present
case). In one patient, both tumors displayed low-grade
glioma. In the present case, the supratentorial tumor
remained low grade, whereas the infratentorial tumor
rapidly proliferated within several months. Of the past
11 reports, only one patient has been reported with
infratentorial tumor rapidly progressing to a malignant
type within a few months after resection of the supraten-
torial tumor.
The pathogenesis of multicentric gliomas remains un-
clear. Many hypotheses have been proposed to explain
the multicentricity. Willis et al. suggested that multi-
centric lesions could result from a two-step process [13].
At first, a large area of the brain, or even the entire
brain, undergoes neoplastic transformation (initiation),
becoming more susceptible to neoplastic growth. In the
second stage (promotion), neoplastic proliferation in
multiple sites occurs after various stimulations. Genetic
and molecular analyses are very useful and important for
elucidating the pathogenesis of multicentric gliomas.
Reis et al. investigated genetic changes to compare
primary and secondary glioblastomas and reported
that these tumors were independent of each other,
with showing a different pattern of genetic mutations
[14]. Furthermore, the phenotype of these tumors in-
cluded genetic mutations of tumor-suppressor genes
such as p53, phosphatase, and tensin homologue de-
leted from chromosome 10 (PTEN) and overexpres-
sion of EGFR. Watanabe et al. indicated that
overexpression of EGFR and mutations of p53 are
mutually exclusive, and the alteration of either gene
leads to different pathways for the evolution of glio-
blastoma as the common phenotypic endpoint [15].
Primary glioblastoma thus occurs by a de novo path-
way with overexpression of EGFR, whereas secondary
glioblastoma develops by a progression pathway in
which p53 mutations operate as an initiation step for
neoplastic transformations less frequently with EGFR
overexpression. In the present case, supratentorial
tumor revealed immunoreactivity for p53, whereas
EGFR showed a negative reaction. The malignant
phenotype derived from this tumor is thus postulated
to represent a secondary glioblastoma. However, facts
that the infratentorial tumor showed positive immu-
noreactivity for both p53 and EGFR, displayed wild-
type IDH1, and had large ischemic necrosis might
make a contradiction if the tumor developed along
the progression pathway [15, 16]. In the present case,
p53 mutations may have occurred throughout the
brain, possibly inducing transformation of the glial
cells as described by Willis et al. The supratentorial
tumor may have developed from a genetic
Fig. 6 Photomicrographs showing histopathology of the cerebellar tumor. Microscopic histology (a) displayed the tumor with high cellularity,
increased tumor vessels, and a pseudopalisading of tumor cells around large necrosis. The microscopic view with high magnification (b) revealed
tumor cells with marked cellular and nuclear anaplasia and the prominent proliferation of vascular endothelial cells and necrosis (hematoxylin
and eosin, a ×100, scale bar: 400 μm, b ×400, scale bar: 50 μm). Immunohistochemistry for MIB-1 showing a high Ki-67 (MIB-1) labeling index
(42.8 %) (c). Immunohistochemistry for p53 (d) and EGFR (e) disclosing strongly positive immunoreactivity of tumor cells for both molecules, but
a negative staining for IDH1 (f). c–f ×400, scale bar: 50 μm
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background of p53 mutations. Taking into consider-
ation the fact that the infratentorial tumor occurred
within a short period of less than 4 months, the ma-
lignant phenotype may have developed through a de
novo pathway. These may be the reasons for positive
stainings of both p53 and EGFR in the infratentoral
tumor. To elucidate the pathogenesis of multicentric
gliomas, further genetic analysis of glioma
oncogenesis-related genes including these molecules
will be necessary with obtaining more critical
information.
Conclusions
We reported a case of multicentric gliomas occurring in
the supra- and infratentorial regions with different histo-
pathology. One tumor was diffuse astrocytoma of the left
insula, while the other was glioblastoma of the cerebel-
lum. Immunohistochemical analysis suggested that these
tumors might have occurred by different pathways of
neoplastic transformation in glial cells.
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